FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
Guggenheim maintains a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and raised the price target to $40.00 (from $35.00), following F3Q15 beat. PAHC reported an adjusted diluted EPS of $0.41 ($0.05 higher than consensus and $0.07 better than Guggenheim estimate). PAHC management raised the '15 EPS guidance from... More
Phibro Animal Health (NASDAQ: PAHC) declared a quarterly dividend of $0.10 per share, or $0.4 annualized.
The dividend will be payable on June 24, 2015, to stockholders of record on June 3, 2015, with an ex-dividend date of June 1, 2015.
The annual yield on the dividend is 1.2... More

